Markets:

Overview

News

Currencies

International

Treasuries

ALX Oncology Holdings Inc. - Common Stock (NQ:ALXO)

2.110 -0.040 (-1.86%)

Streaming Delayed Price Updated: 11:22 AM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ALX Oncology Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Cal-Maine Foods, A10 Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 04, 2023

U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Crude Oil Moves Higher; POINT Biopharma Global Shares Jump ↗

October 03, 2023

U.S. stocks extended losses toward the end of trading, with the S&P 500 falling around 1.5% on Tuesday. The Dow traded down 1.43% to 32,954.84 while the NASDAQ fell 1.98% to 13,044.24. The S&P 500 also...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 03, 2023

Via Benzinga

Why ALX Oncology Stock Is Skyrocketing Today ↗

October 03, 2023

Investors are cheering the immuno-oncology company's latest clinical trial results.

Via The Motley Fool

Where ALX Oncology Holdings Stands With Analysts ↗

September 07, 2023

Via Benzinga

4 Analysts Have This to Say About ALX Oncology Holdings ↗

August 11, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About ALX Oncology Holdings ↗

May 12, 2023

Via Benzinga

Recap: ALX Oncology Holdings Q1 Earnings ↗

May 11, 2023

Via Benzinga

Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 03, 2023

Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company.

Via Benzinga

ALX Oncology Holdings Inc. (NASDAQ: ALXO) is One of Tuesday Morning’s Most Active Stocks

October 03, 2023

Via Investor Brand Network

'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories ↗

October 03, 2023

Benzinga

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 03, 2023

Via Benzinga

Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today? ↗

October 03, 2023

ALX Oncology Holdings Inc (NASDAQ: ALXO) released prespecified interim Phase 2 data from its ASPEN-06 trial of evorpacept plus trastuzumab, Cyramza (ramucirumab) and paclitaxel for HER2-positive...

Via Benzinga

Why Delta Apparel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 03, 2023

Gainers VIQ Solutions Inc. (NASDAQ: VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq.

Via Benzinga

S&P 500, Nasdaq Futures Waver As Focus Turns To JOLTS Data: Why These Analysts Say Expecting A Strong Q4 This Year Is 'Tricky' ↗

October 03, 2023

Index futures point to a modestly higher opening on Tuesday, while 10-year Treasury yields have surged to over 4.70%, adding to uncertainty about interest rates.

Via Benzinga

Topics Stocks

ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer

October 03, 2023

From ALX Oncology

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 02, 2023

Via Benzinga

ALX Oncology to Host Investor Call and Webcast on October 3, 2023 to Share Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer

October 02, 2023

From ALX Oncology

Via GlobeNewswire

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023

Via Investor Brand Network

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023

EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END

Via FinancialNewsMedia

ALX Oncology Realigns Executive Leadership Team

September 06, 2023

From ALX Oncology

Via GlobeNewswire

ALX Oncology Announces September Investor Conference Participation

August 31, 2023

From ALX Oncology

Via GlobeNewswire

ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update

August 10, 2023

From ALX Oncology

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 06, 2023

Via Benzinga

Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session ↗

July 06, 2023

Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.

Via Benzinga

ALX Oncology Receives Orphan Drug Designation from the European Commission for Evorpacept for the Treatment of Patients with Gastric Cancer

June 26, 2023

From ALX Oncology

Via GlobeNewswire

ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights

May 11, 2023

From ALX Oncology

Via GlobeNewswire

ALX Oncology Announces First Patient Dosed in Phase 2 Investigator-Sponsored Trial of Evorpacept in Patients with Ovarian Cancer

May 09, 2023

From ALX Oncology

Via GlobeNewswire

ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma

April 25, 2023

From ALX Oncology

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.